CheckMan Stock Market Overview

Salesforce leverages its deep enterprise footprint to accelerate AI adoption, aiming to boost wallet share and drive organic growth. CRM's AI layer is scaling rapidly, with Agentforce ARR up 240%+ and strong sequential growth in agentic work units and premium bookings. Valuation remains reasonable at a 14.88x forward P/E, with base case upside to $285–$315 if AI monetization and organic growth materialize.

RUSTON, La., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Origin Bancorp, Inc. (NYSE: OBK) ("Origin"), the holding company for Origin Bank, announced today that it will transfer its stock exchange listing from the New York Stock Exchange (“NYSE”) to the Texas Stock Exchange (“TXSE”).

SAN DIEGO, CA / ACCESS Newswire / September 15, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), hosted a symposium at PainWeek 2026. The Symposium was attended by more than 320 pain management professionals.

FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocol Initiation of Phase 1 trial in MM patients contingent upon timing and receipt of non-dilutive grant funding Phase 1 dose escalation basket trial with GTB-5550 in solid tumor patients continues to actively enroll, with an update anticipated in Q4 2026 Unaudited proforma cash balance as of September 15, 2026 of approximately $11 million anticipated to provide sufficient cash runway into Q3 2027 SAN FRANCISCO, CALIFORNIA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced IND clearance from the FDA for GTB-5550 in multiple myeloma.

MIDLAND, VA / ACCESS Newswire / September 15, 2026 / Smith-Midland Corporation (NASDAQ:SMID), a leading manufacturer of innovative precast concrete products for transportation, infrastructure, and building construction, has secured a $2.2 million contract to manufacture and supply SlenderWall® architectural precast panels, architectural precast components, and precast stair systems for a new operations and office facility at Newport News Shipbuilding in Newport News, Virginia. The award further strengthens Smith-Midland's position in the architectural precast market while expanding its portfolio of projects serving government, industrial, and mission-critical infrastructure.

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Today, Food & Wine, a People Inc. brand, reveals its 2026 Best New Chefs, sponsored by Resy and American Express, recognizing 14 extraordinary chefs across 10 restaurants whose cooking is helping define the next era of American dining.

More than 3.5 million tons hauled autonomously in 18-month pilot drives expansion to two additional Luck Stone quarries to enhance safety, consistency and new opportunities for associates. Quarry automation gains momentum with first-ever deployment of autonomous haulage solution on a Cat® 775 IRVING, Texas, Sept.

Shares of Dave & Buster's Entertainment PLAY plunged 13.6% in premarket trading on Tuesday after the arcade and entertainment chain reported second-quarter fiscal 2026 results that missed Wall Street expectations on both revenue and earnings. The company swung to a quarterly loss as it continued to struggle with declining entertainment sales and efforts to rebuild its relevance with customers.

Change is afoot at Apple (AAPL), providing traders with ample opportunity to embrace one of the world's largest companies by market value, and perhaps single-stock ETFs such as the Direxion Daily AAPL Bull 2X Shares (AAPU). AAPU attempts to deliver performances that equate to 200% of the daily moves of Apple shares.

Barring a reversal of epic proportions in the final three and a half months of 2026, value stocks and the related ETFs will likely again lag their growth counterparts when this year draws to a close. That doesn't mean value investing is dead.